Vitamin D and Osteoblasts

Vitamin D

Volumn 1, Issue , 2005, Pages 649-663

  Aubin, Jane E ^a   Heersche, Johan ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747847044     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012252687-9/50040-1     Document Type: Chapter

References (183)

1. Studzinski GP, McLane JA, Uskokovic MR Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot ot Gene Expr 1993, 3:279-312.
2. Bikle DD, Pillai S Vitamin D, calcium, and epidermal differentiation. Endocr Rev 1993, 14:3-19.
3. Eckert RL, Crish JF, Robinson NA The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 1997, 77:397-424.
4. Bikle DD Vitamin D regulated keratinocyte differentiation. J Cell Biochem 2004, 92:436-444.
5. Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N The molecular basis of osteoclast differentiation and activation. Novartis Found Symp 2001, 232:235-247.
6. Suda T, Ueno Y, Fujii K, Shinki T Vitamin D and bone. J Cell Biochem 2003, 88:259-266.
7. 3 stimulates adipocyte differentiation in cultures of fetal rat calvarial cells: Comparison with the effects of dexamethasone. Endocrinol 1994, 134:2221-2229.
8. Vu D, Ong JM, Clemens TL, Kern PA 1,25-Dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation. Endocrinology 1996, 137:1540.
9. Atmani H, Chappard D, Basle MF Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol. J Cell Biochem 2003, 89:364-372.
10. 3 on induction of chondrocyte maturation in culture: extracellular matrix gene expression and morphology. Endocrinology 1990, 126:1599-1609.
11. 3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. Endocrinology 1992, 130:2495-2504.
12. Lin R, White JH The pleiotropic actions of vitamin D. Bioessays 2004, 26:21-28.
13. Banerjee P, Chatterjee M Antiproliferative role of vitamin D and its analog-a brief overview. Mol Cell Biochem 2003, 253:247-254.
14. Farach-Carson MC, Nemere I Membrane receptors for vitamin D steroid hormones: Potential new drug targets. Curr Drug Targets 2003, 4:67-76.
15. 3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. Crit Rev Oral Biol Med 2002, 13:143-154.
16. 3 receptor-like macromolecule in rat osteogenic sarcoma cell lines. J Biol Chem 1980, 255:4414-4417.
17. 3 receptors in cultured mouse bone cells. Correlation of receptor concentration with the rate of cell division. J Biol Chem 1981, 256:5561-5566.
18. 3 in bones from fetal rats. Calcif Tissue Int 1983, 35:177-182.
19. 3 receptor levels in tumor and nontumor cells derived from rat bone. J Natl Cancer Inst 1987, 78:265-270.
20. 3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem 1982, 257:3362-3365.
21. 3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 1981, 256:7115-7117.
22. 3 on alkaline phosphatase activity and collagen synthesis in osteoblastic cells, clone MC3T3-E1. Biochem Biophys Res Commun 1984, 119:767-771.
23. 3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation. Endocrinology 1986, 119:1776-1785.
24. 3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. Coll Relat Res 1987, 7:305-313.
25. 3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells. Cancer Res 1991, 51:2144-2150.
26. Sodek J, Chen J, Nagata T, Kasugai S, Todescan R, Li J, Kim RH Regulation of osteopontin expression in osteoblasts. Ann NY Acad Sci 1995, 760:223-241.
27. 3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J Biol Chem 1980, 255:11660-11663.
28. Raisz LG, Maina DM, Gworek SC, Dietrich JW, Canalis EM Hormonal control of bone collage synthesis in vitro: Inhibitory effect of 1-hydroxylated vitamin D metabolites. Endocrinology 1978, 102:731-735.
29. Kream BE, Rowe D, Smith MD, Maher V, Majeska R Hormonal regulation of collagen synthesis in a clonal rat osteosarcoma cell line. Endocrinology 1986, 119:1922-1928.
30. Oldberg A, Jirskog-Hed B, Axelsson S, Heinegard D Regulation of bone sialoprotein mRNA by steroid hormones. J Cell Biol 1989, 109:3183-3186.
31. Sodek J, Kim RH, Ogata Y, Li J, Yamauchi M, Zhang Q, Freedman LP Regulation of bone sialoprotein gene transcription by steroid hormones. Connect Tissue Res 1995, 32:209-217.
32. van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr 2001, 11:199-226.
33. 3 effects on collagen and DNA synthesis in periosteum and periosteum-free calvaria. Bone 1985, 6:457-460.
34. 3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. Endocrinology 1989, 125:327-333.
35. Nefussi JR, Boy-Lefevre ML, Boulekbache H, Forest N Mineralization in vitro of matrix formed by osteoblasts isolated by collagenase digest. Differentiation 1985, 29:160-168.
36. Bellows CG, Aubin JE, Heersche JNM, Antosz ME Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986, 38:143-154.
37. Aubin JE, Triffitt J Mesenchymal stem cells and the osteoblast lineage. Principles of Bone Biology 2002, 59-81. Academic Press, New York. 2nd ed. J.P. Bilezikian, L.G. Raisz, G.A. Rodan (Eds.).
38. Bhargava U, Bar-Lev M, Bellows CG, Aubin JE Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 1988, 9:155-163.
39. Malaval L, Modrowski D, Gupta AK, Modrowski D, Gupta AK, Aubin JE Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 1994, 158:555-572.
40. Malaval L, Liu F, Roche P, Aubin JE Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J Cell Biochem 1999, 74:616-627.
41. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990, 143:420-430.
42. Liu F, Malaval L, Gupta A, Aubin JE Simultaneous detection of multiple bone-related mRNAs and protein expression during osteoblast differentiation: Polymerase chain reaction and immunocytochemical studies at the single cell level. Dev Biol 1994, 166:220-234.
43. Liu F, Malaval L, Aubin JE Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation. J Cell Sci 2003, 116:1787-1796.
44. Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, van Wijnen AJ, Stein GS Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 2004, 14:1-41.
45. Mechanisms Regulating Osteoblast Proliferation and Differentiation 1996, Academic Press, San Diego. G.S. Stein, J.B. Lian, J.L. Stein, A.J. van Wijnen, B. Frenkel, M. Montecino (Eds.).
46. Aubin JE, Heersche JNM Bone cell biology: osteoblasts, osteocytes and osteoclasts. Pediatric Bone 2002, 43-75. Academic Press, San Diego. F.H. Glorieux, J.M. Pettifor, H. Jueppner (Eds.).
47. Rodan GA Control of bone formation and resorption: biological and clinical perspective, 25th anniversary issue: New directions and dimensions in cellular biochemistry. J Cell Biochem Suppl 1998, 30/31:55-61.
48. Aubin JE Regulation of osteoblast differentiation and function. Rev Endoc and Metabol Disorders 2001, 2:81-94.
49. Bellows CG, Aubin JE, Heersche JNM Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 1987, 121:1985-1992.
50. Bellows CG, Aubin JE Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. Dev Biol 1989, 133:8-13.
51. Bellows CG, Heersche JNM, Aubin JE Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence of dexamethasone. Dev Biol 1990, 140:132-138.
52. Turksen K, Aubin JE Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J Cell Biol 1991, 114:373-384.
53. Ellies LG, Aubin JE Temporal sequence of interleukin 1α-mediated stimulation and inhibition of bone formation by isolated fetal rat calvarial cells in vitro. Cytokine 1990, 2:430-437.
54. Owen TA, Aronow MA, Barone LM, Bettencourt B, Stein G, Lian JB Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991, 128:1496-1504.
55. 3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvarial cells. Endocrinology 1993, 132:61-66.
56. 3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells. Endocrinology 1986, 118:1340-1346.
57. 3 and glucocorticoids on the growth of rat and mouse osteoblast-like bone cells. Calcif Tissue Int 1983, 35:806-811.
58. Harrison JR, Clark NB Avian medullary bone in organ culture: Effects of vitamin D metabolites on collagen synthesis. Calcif Tissue Int 1986, 39:35-43.
59. Bringhurst FR, Potts JT Effects of vitamin D metabolites and analogs on bone collagen synthesis in vitro. Calcif Tissue Int 1982, 34:103-110.
60. 3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts. J Cell Biochem 1995, 57:440-451.
61. Gerstenfeld LC, Zurakowski D, Zurakowski J.L.S., Nichols DP, Toma CD, Broess M, Bruder SP, Caplan AI Variable hormone responsiveness of osteoblast populations isoalted at different stages of embryogenesis and its relationship to the osteogenic lineage. Endocrinology 1996, 137:3957-3968.
62. 3, dexamethasone, and local growth factors in primary human osteoblasts. J Cell Biochem 2002, 86:348-356.
63. 3 stimulates the synthesis of matrix gamma-carboxyglutamine acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines. J Biol Chem 1988, 263:911-916.
64. 3 treatment of osteosarcoma cells. Calcif Tissue Int 1990, 46:270-279.
65. 3 and ascorbic acid in bone-derived cells. J Bone Miner Res 1990, 5:1157-1167.
66. 3 in human osteosarcoma cells. J Biol Chem 1988, 263:18938-18945.
67. 3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells. Bone 1991, 12:27-32.
68. Wergedal JE, Baylink DJ Characterization of cells isolated and cultured from human bone. Proc Soc Exp Biol Med 1984, 176:60-69.
69. Auf'mkolk B, Hauschka PV, Schwartz ER Characterization of human bone cells in culture. Calcif Tissue Int 1985, 37:228-235.
70. Robey PG, Termine JD Human bone cells in vitro. Calcif Tissue Int 1985, 37:453-460.
71. Marie PJ, Lomri A, Sabbagh A, Basle M Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces. In Vitro Cell Dev Biol 1989, 25:373-380.
72. Rodan GA, Heath JK, Yoon K, Noda M, Rodan SB Diversity of the osteoblastic phenotype. Ciba Found Symp 1988, 136:78-91.
73. Marie PJ Human osteoblastic cells: a potential tool to assess the etiology of pathologic bone formation. J Bone Miner Res 1994, 9:1847-1850.
74. Bodine PV, Komm BS Tissue culture models for studies of hormone and vitamin action in bone cells. Vitam Horm 2002, 64:101-151.
75. 3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 1994, 39:941-947.
76. Leboy PS, Beresford JN, Devlin C, Owen ME Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J Cell Physiol 1991, 146:370-378.
77. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 1996, 11:312-324.
78. Walsh S, Dodds RA, James IE, Bradbeer JN, Gowen M Monoclonal antibodies with selective reactivity against osteoblasts and osteocytes in human bone. J Bone Miner Res 1994, 9:1687-1696.
79. 3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Differentiation 1994, 55:153-163.
80. 3. Bone 1993, 14:763-767.
81. Ninomiya JT, Tracy RP, Calore JD, Gendreau MA, Kelm RJ, Mann KG Heterogeneity of human bone. J Bone Miner Res 1990, 5:933-938.
82. Chen J, Shapiro HS, Wrana JL, Reimers S, Heersche JNM, Sodek J Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization. Matrix 1991, 11:133-143.
83. Chen J, Singh K, Mukherjee BB, Sodek J Developmental expression of osteopontin (OPN) mRNA in rat tissues: Evidence for a role for osteopontin in bone formation and resorption. Matrix 1993, 13:113-123.
84. Heersche JNM, Reimers S, Wrana JL, Waye MMY, Gupta AK Changes in expression of α1 type 1 collagen and osteocalcin mRNA in osteoblasts and odontoblasts at different stages of maturity as shown by in situ hybridization. Proc Finn Dent Soc 1992, 88:173-182.
85. Ingram RT, Clarke BL, Fisher LW, Fitzpatrick LA Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J Bone Miner Res 1993, 8:1019-1029.
86. Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 2001, 107:277-286.
87. Candeliere GA, Liu F, Aubin JE Individual osteoblasts in the developing calvaria express different gene repertoires. Bone 2001, 28:351-361.
88. Aubin JE, Candeliere GA, Bonnelye E Heterogeneity of the osteoblast phenotype. Endocrinologist 1999, 9:25-31.
89. Liu F, Malaval L, Aubin JE The mature osteoblast phenotype is characterized by extensive plasticity. Exp Cell Res 1997, 232:97-105.
90. 3 and glucocorticoids during differentiation of the osteoblast phenotype: Interrelationships of morphology and gene expression by in situ hybridization. Exp Cell Res 1995, 216:244-260.
91. 3. Cell Tissue Res 1999, 297:249-259.
92. Prince M, Banerjee C, Javed A, Green J, Lian JB, Stein GS, Bodine PV, Komm BS Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem 2001, 80:424-440.
93. Aubin JE, Gupta AK, Bhargava U, Turksen K Expression and regulation of galectin 3 in rat osteoblastic cells. J Cell Physiol 1996, 169:468-480.
94. Weinreb M, Shinar D, Rodan GA Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res 1990, 5:831-842.
95. 3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells. Bone 1995, 16:671-678.
96. Herbertson A, Aubin J Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. J Bone Miner Res 1995, 10:285-294.
97. Long MW, Robinson JA, Mann KG Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 1995, 95:881-887.
98. Eipers PG, Kale S, Taichman RS, Pipia GG, Swords NA, Mann KG, Long MW Bone marrow accessory cells regulate human bone precursor cell development. Exp Hematol 2000, 28:815-825.
99. Lian JB, Stein JL, Stein GS, Montecino M, van Wijnen AJ, Javed A, Gutierrez S Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene. Steroids 2001, 66:159-170.
100. Lian JB, Stein GS The temporal and spatial subnuclear organization of skeletal gene regulatory machinery: integrating multiple levels of transcriptional control. Calcif Tissue Int 2003, 72:631-637.
101. Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone 1995, 17:33S-38S.
102. White C, Gardiner E, Eisman J Tissue specific and vitamin D responsive gene expression in bone. Mol Biol Rep 1998, 25:45-61.
103. Lian JB, Stein GS, Stein JL, van Wijnen AJ Regulated expression of the bone-specific osteocalcin gene by vitamins and hormones. Vitam Horm 1999, 55:443-509.
104. Fernandez-Martin JL, Kurian S, Farmer P, Nanes MS Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors. Mol Cell Endocrinol 1998, 141:65-72.
105. Godschalk M, Levy JR, Downs RW Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells. J Bone Miner Res 1992, 7:21-27.
106. 3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology 1996, 137:2001-2011.
107. 3. Crit Rev Eukaryot Gene Expr 2001, 11:299-317.
108. Franceschi RT Functional cooperativity between osteoblast transcription factors: evidence for the importance of subnuclear macromolecular complexes?. Calcif Tissue Int 2003, 72:638-642.
109. McCabe LR, Kockx M, Lian J, Stein J, Stein G Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. Exp Cell Res 1995, 218:255-262.
110. Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 2000, 6:985-990.
111. Candeliere GA, Prud'homme J, St-Arnaud R Differential stimulation of fos and jun family members by calcitriol in osteoblastic cells. Mol Endocrinol 1991, 5:1780-1788.
112. 3 in bone cells. Biochim Biophys Acta 1993, 1174:11-16.
113. Jabs EW, Muller U, Li X, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB, Snead ML, Maxson R A mutation in the homeodomain of the human Msx-2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993, 785:443-450.
114. Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T, Takano Y, Uchiyama M, Heaney S, Peters H, Tang Z, Maxson R, Maas R Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 2000, 24:391-395.
115. Ishii M, Merrill AE, Chan YS, Gitelman I, Rice DP, Sucov HM, Maxson RE Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 2003, 130:6131-6142.
116. Hoffmann HM, Catron KM, van Wijnen AJ, McCabe LR, Lian JB, Stein GS, Stein JL Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. Proc Natl Acad Sci USA 1994, 91:12887-128891.
117. Towler DA, Rutledge SJ, Rodan GA Msx-2/Hox 8.1: A transcriptional regulator of the rat osteocalcin promoter. Mol Endocrinol 1994, 8:1484-1493.
118. Ryoo HM, Hoffmann HM, Beumer T, Frenkel B, Towler DA, Stein GS, Stein JL, van Wijnen AJ, Lian JB Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol 1997, 11:1681-1694.
119. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996, 10:142-153.
120. Atkinson MJ, Freeman MW, Kronenberg HM Thymosin beta 4 is expressed in ROS 17/2.8 osteosarcoma cells in a regulated manner. Mol Endocrinol 1990, 4:69-74.
121. 3 regulates in vivo production of the third component of complement (C3) in bone. Endocrinology 1992, 131:2468-2475.
122. Sato T, Abe E, Jin CH, Hong MH, Katagiri T, Kinoshita T, Amizuka N, Ozawa H, Suda T The biological roles of the third component of complement in osteoclast formation. Endocrinology 1993, 133:397-404.
123. Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino AC RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 2003, 18:1088-1098.
124. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20:345-357.
125. Aubin JE, Bonnelye E Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 2000, 11:905-913.
126. Homme M, Schmitt CP, Himmele R, Hoffmann GF, Mehls O, Schaefer F Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells. Endocrinology 2003, 144:2496-2504.
127. 3. J Cell Biochem 1993, 53:122-134.
128. 3. J Clin Invest 1993, 91:1731-1742.
129. 3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NFκ B ligand production in osteoblasts. J Immunol 2002, 169:2374-2380.
130. Kim CH, Kang BS, Lee TK, Park WH, Kim JK, Park YG, Kim HM, Lee YC IL-1 beta regulates cellular proliferation, prostaglandin E2 synthesis, plasminogen activator activity, osteocalcin production, and bone resorptive activity of the mouse calvarial bone cells. Immunopharmacol Immunotoxicol 2002, 24:395-407.
131. Jehan F, Naveilhan P, Neveu I, Harvie D, Dicou E, Brachet P, Wion D Regulation of NGF, BDNF and LNGFR gene expression in ROS 17/2.8 cells. Mol Cell Endocrinol 1996, 116:149-156.
132. 3-mediated nerve growth factor expression in osteoblasts. Biochemistry 1998, 37:5988-5994.
133. 3. Mol Pharmacol 1995, 47:266-271.
134. Kasperk CH, Borcsok I, Schairer HU, Schneider U, Nawroth PP, Niethard FU, Ziegler R Endothelin-1 is a potent regulator of human bone cell metabolism in vitro. Calcif Tissue Int 1997, 60:368-374.
135. Rosen H, Krichevsky A, Polakiewicz RD, Benzakine S, Bar-Shavit Z Developmental regulation of proenkephalin gene expression in osteoblasts. Mol Endocrinol 1995, 9:1621-1631.
136. 3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells. J Bone Miner Res 1993, 8:1453-1458.
137. 3 and TGF-betal on the production of insulin-like growth factor binding protein 3 in human bone marrow stromal cell cultures. APMIS 2002, 110:410-414.
138. 3 and thyroid hormone in three osteosarcoma cell lines. Endocrinology 1995, 136:4304-4314.
139. 3 and thyroid hormone in three osteosarcoma cell lines. J Endocrinol 1997, 154:63-74.
140. Ohishi K, Nishikawa S, Nagata T, Yamauchi N, Shimohara H, Kido J, Ishida H Physiological concentrations of retinoic acid suppress the osteoblastic differentiation of fetal rat calvaria cells in vitro. Eur J Endocrinol 1995, 133:335-341.
141. Ohishi K, Ishida H, Nagata T, Yamauchi N, Tsurumi C, Nishikawa S, Wakano Y Thyroid hormone suppresses the differentiation of osteoprogenitor cells to osteoblasts, but enhances functional activities of mature osteoblasts in cultured rat calvaria cells. J Cell Physiol 1994, 161:544-552.
142. Ishida H, Bellows CG, Aubin JE, Heersche JNM Triiodothyronine (T3) and dexamethasone interact to modulate osteoprogenitor cell differentiation in fetal rat calvaria cell cultures. Bone 1994, 16:545-549.
143. Choong PF, Martin TJ, Ng KW Effects of ascorbic acid, calcitriol, and retinoic acid on the differentiation of preosteoblasts. J Orthop Res 1993, 11:638-647.
144. Chapman AB, Knight DM, Ringold GM Glucocorticoid regulation of adipocyte differentiation: Hormonal triggering of the developmental program and induction of a differentiation-dependent gene. J Cell Biol 1985, 101:1227-1235.
145. Schiwek DR, Loffler G Glucocorticoid hormones contribute to the adipogenic activity of human serum. Endocrinology 1987, 120:469-474.
146. Deryugina EI, Ratnikov BI, Bourdon MA, Muller-Sieburg CE Clonal analysis of primary marrow stroma: functional homogeneity in support of lymphoid and myeloid cell lines and identification of positive and negative regulators. Exp Hematol 1994, 22:910-918.
147. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteogenic disorders. J Bone Miner Res 1998, 13:371-382.
148. 3 receptor-like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation. J Cell Physiol 1988, 135:545-550.
149. 3 in proliferation and differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 1988, 151:1122-1127.
150. Kawada T, Aoki N, Kamei Y, Maeshige K, Nishiu S, Sugimoto E Comparative investigation of vitamins and their analogs on terminal differentiation, from preadipocytes to adipocytes, of 3T3-L1 cells. Comp Biochem Physiol A 1990, 96:323-326.
151. Kawada T, Kamei Y, Sugimoto E The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand-dependent transcriptional regulators. Int J Obes Relat Metab Disord 1996, 20:S52-S57.
152. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat bone marrow stromal cell cultures. J Cell Sci 1992, 102:341-351.
153. 3 modulation in lipid metabolism in established bone marrow-derived stromal cells, MC3T3-G2/PA6. J Cell Biochem 1992, 48:424-430.
154. 3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 1998, 139:2622-2628.
155. Falla N, Van Vlassalaer P, Bierkens J, Borremans B, Schoeters G, Van Gorp U Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood 1993, 82:3580-3591.
156. Bellows CG, Ciaccia A, Heersche JN Osteoprogenitor cells in cell populations derived from mouse and rat calvaria differe in their response to corticosterone, cortisol, and cortisone. Bone 1998, 23:119-125.
157. Meunier P, Aaron J, Edouard C, Vignon G Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop 1971, 80:147-154.
158. Burkhardt R, Kettner G, Bohm W, Schmidmeier M, Schlag R, Frisch B, Mallmann B, Eisenmenger W, Gilg T Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone 1987, 8:157-164.
159. Rozman C, Feliu E, Berga L, Reverter JC, Climent C, Ferran MJ Age-related variations of fat tissue fraction in normal human bone marrow depend both on size and number of adipocytes: A sterological study. Exp Hematol 1989, 17:34-37.
160. Minaire P, Edouard C, Arlot M, Meunier PJ Marrow changes in paraplegic patients. Calcif Tissue Int 1984, 36:338-340.
161. Gimble JM, Robinson CE, Kelly KA The function of adipocytes in the bone marrow stroma: An update. Bone 1996, 19:421-428.
162. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001, 2:165-171.
163. Wronski TJ, Morey-Holton E, Jee WS Skeletal alterations in rats during space flight. Adv Space Res 1981, 1:135-140.
164. Martin RB, Zissimos SL Relationships between marrow fat and bone turnover in ovariectomized and intact rats. Bone 1991, 12:123-131.
165. Kajkenova O, Lecka-Czernik B, Gubrij I, Hauser SP, Takahashi K, Parfitt AM, Jilka RL, Manolagas SC, Lipschitz DA Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res 1997, 12:1772-1779.
166. Nuttall ME, Gimble JM Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?. Bone 2000, 27:177-184.
167. Gimble JM, Nuttall ME Bone and fat: old questions, new insights. Endocrine 2004, 23:183-188.
168. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 1999, 74:357-371.
169. Aubin JE Your partner makes all the difference IBMS-BoneKEy. http://www.bonekey/ibms.org/cgi/content/full//ibmske;2001013v1.
170. Kveiborg M, Sabatakos G, Chiusaroli R, Wu M, Philbrick WM, Horne WC, Baron R DeltaFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol Cell Biol 2004, 24:2820-2830.
171. Bellows CG, Heersche JN The frequency of common progenitors for adipocytes and osteoblasts and of committed and restricted adipocyte and osteoblast progenitors in fetal rat calvaria cell populations. J Bone Miner Res 2001, 16:1983-1993.
172. Tam CS, Jones G, Heersche JN The effect of vitamin D restriction and repletion on bone apposition in the rat and its dependence on parathyroid hormone. Endocrinology 1981, 109:1448-1453.
173. Tam CS, Heersche JN, Jones G, Murray TM, Rasmussen H The effect of vitamin D on bone in vivo. Endocrinology 1986, 118:2217-2224.
174. 3 in long bones of rats. Calcif Tissue Int 1986, 38:79-86.
175. 3 promotes bone formation without causing excessive resorption in hypophosphatemic mice. Endocrinology 1996, 137:2633-2637.
176. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997, 16:391-396.
177. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 1997, 94:9831-9835.
178. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998, 139:4391-4396.
179. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 2001, 98:7498-7503.
180. 3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
181. 3: Biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res 2003, 18:637-643.
182. Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, St-Arnaud R Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1). Bone 2003, 32:332-340.
183. St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, Chapin K, Depovere J, Mathieu C, Christakos S, Demay MB, Glorieux FH Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 2000, 141:2658-2666.